Vera Therapeutics (VERA) Long-Term Investments (2021 - 2023)

Vera Therapeutics (VERA) has 3 years of Long-Term Investments data on file, last reported at $11000.0 in Q4 2023.

• Quarterly Long-Term Investments fell 81.03% year-over-year to $11000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $11000.0 (down 81.03% YoY) and the FY2023 annual result came in at $11000.0, down 81.03% from the prior year.
• Long-Term Investments declined to $11000.0 in Q4 2023, from $13000.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $1.5 million in Q2 2021 to a low of $11000.0 in Q4 2023.
• A 3-year average of $423000.0 and a median of $122000.0 in 2022 frame the typical range for Long-Term Investments.
• The widest YoY moves for Long-Term Investments: up 78.08% in 2022, down 93.31% in 2022.
• Tracing VERA's Long-Term Investments over 3 years: stood at $867000.0 in 2021, then slumped by 93.31% to $58000.0 in 2022, then sank by 81.03% to $11000.0 in 2023.
• The last three Long-Term Investments figures came in at $11000.0 (Q4 2023), $13000.0 (Q3 2023), and $29000.0 (Q2 2023), per Business Quant data.